COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
AMO Pharma is a biopharmaceutical company developing therapies for rare genetic disorders, advancing AMO-02 into Phase II for myotonic dystrophy type 1 and AMO-01 for fragile X.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor